Searchable abstracts of presentations at key conferences on calcified tissues

ba0007p30 | (1) | ICCBH2019

Bone mass, sclerostin and body composition in women with anorexia nervosa: a 3-year follow-up after weight gain therapy

Svedlund Anna , Tubic Bojan , Pettersson Cecilia , Elfvin Anders , Ellegard Lars , Magnusson Per , Swolin-Eide Diana

Objectives: Patients with anorexia nervosa (AN) are at high risk of reduced bone mass. The aim of this intervention study was to investigate the long-term effects on bone and body composition three years after intense weight gain therapy.Methods: Twenty-five female AN patients, mean age 20.1 years, mean BMI of 15.5 kg/m2, were included. Twenty-two patients fulfilled the treatment for 12 weeks with a high-energy diet. Body composition and bone ...

ba0002p37 | (1) | ICCBH2013

Reduction in bisphosphonate side effect profile using short-term steroid cover

Biggin Andrew , McLean Tina , McQuade Mary , Cowell Chris , Munns Craig

Objectives: Bisphosphonate infusions are associated with numerous adverse effects including acute systemic inflammatory reactions and electrolyte abnormalities. The aims of this study were to evaluate the safety and efficacy of a 3-day course of prednisone on children receiving their first dose of pamidronate or zoledronic acid.Methods: A retrospective cohort of 166 patients (85 males) were commenced on pamidronate (16%) or zoledronic acid (84%) for trea...

ba0004p127 | (1) | ICCBH2015

The outcomes of a standardized approach to managing metabolic bone disease of prematurity

Chin Lit Kim , Doan John , Teoh Yvonne Sui Lien , Stewart Alice , Forrest Peter , Simm Peter J

Metabolic bone disease (MBD) of prematurity is a well-recognized complication of preterm birth. Yet there is limited evidence for the optimal assessment, monitoring, and subsequent bone health management.Retrospective audit of 171 infants born <32 weeks’ gestation between November 2012 and January 2014 at three Monash Health neonatal units (Melbourne, Australia) was undertaken. Infants had mean gestational age (GA) 28.6±2.1 weeks and birth ...

ba0001pp237 | Cell biology: osteocytes | ECTS2013

Nucleotide and mechanically induced ATP release pathways in osteocytes

Kringelbach Tina M , Novak Ivana , Schwarz Peter , Jorgensen Niklas Rye

Background: We have previously shown that MLO-Y4 osteocytes express a number of P2 receptors, respond to a broad range of nucleotides (e.g. UTP) by increasing intracellular calcium concentration and release ATP upon both mechanical and UTP stimulation. The aim of this study therefore is to investigate how the osteocytes release ATP and whether there is a difference in release pathway depending on the type of stimulus.Methods: ATP release was investigated...

ba0001pp286 | Muscle, physical activity and bone | ECTS2013

Muscle function and quality of life in primary hyperparathyroidism

Rolighed Lars , Amstrup Anne Kristine , Jakobsen Niels Frederik Breum , Sikjaer Tanja , Mosekilde Leif , Christiansen Peer , Rejnmark Lars

Introduction: In spite of the frequent encounter of ‘asymptomatic’ primary hyperparathyroidism (PHPT), the patients often describe various relevant improvements postoperatively suggesting a subclinical biological effect of elevated PTH or hypercalcaemia.Materials and methods: To evaluate muscle function, postural stability, and quality of life (QoL) in untreated PHPT, we assessed maximal isometric muscle strength in upper and lower extremities,...

ba0001pp373 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Prevalence of vitamin D deficiency and low bone mineral density in healthy Saudi women

Hussein Khulood , Alkadi Hanan , Lanham-New Susan , Ardawi Mohamad

Introduction and aims: Vitamin D deficiency is a prevalent disorder in developing countries. Clinical manifestations of the deficiency include musculoskeletal disorders, such as nonspecific muscle pain, poor muscle strength and low bone mineral density (BMD). The aim of this study was to determine the prevalence of vitamin D deficiency and low BMD in healthy Saudi women.Methods: The subjects of this cross-sectional study comprised 449 healthy Saudi women...

ba0001pp412 | Osteoporosis: treatment | ECTS2013

Preoperative bisphosphonate treatment in patients with neuromuscular scoliosis improves bone strength of vertebral body

Kashii Masafumi , Nagamoto Yukitaka , Fujimori Takahito , Honda Hirotsugu , Kaito Takashi , Yoshikawa Hideki , Iwasaki Motoki

Background: Boys with muscular dystrophy as presented by Duchenne muscular dystrophy (DMD) lose muscle strength and are usually confined to a wheelchair until 13 years. Furthermore they often have development of myogenic scoliosis, and scoliosis surgery is necessary to acquire sitting balance. Osteoporosis is one of the major concerns to perform surgical treatment. Patients with DMD or congenital muscular dystrophy (CMD) have fragile bones due to loss of ambulation, glucocorti...

ba0001pp489 | Other diseases of bone and mineral metabolism | ECTS2013

Homeostasis of calcium and vitamin D in patients with aggressive periodontitis

Zyablitskaya Maria , Atrushkevich Victoria , Mkrtumian Ashot

Aim: Periodontologists all over the world are more and more interested in connection between pathogenesis of aggressive periodontitis (AP) and calcium and vitamin D metabolic disturbances. Vitamin D besides its direct effect on calcium homeostasis, has immunomodulatory action, that makes interesting the study of vitamin D effect on pathogenesis of AP.Materials and methods: We studied 102 (49 males; 53 females) patients with AP (40.32±1.13), 42 patie...

ba0002p49 | (1) | ICCBH2013

Some features of regulation of the bone tissue metabolisms at the newborns who have transferred infectious influence during intrauterine development

Manasova Gulsym , Povoroznyuk Vladyslav , Zelinsky Alexander

Perinatal infections appreciably defines the level’s of the neonatal deseases and death rates. The systemic inflammatory response syndrome at the infections can promote the softening of the bone’s tissue in pregnant women and their fetuses.Objectives: Definition of the connection of the level’s calcium-regulated hormones and bone tissue remodeling marker’s in blood at 32 (II) healthy and 48 (I) pregnant women with perinatal infections...

ba0002p90 | (1) | ICCBH2013

Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia

Skalova Sylva , Kutilek Stepan , Cerna Lucie , Bayer Milan , Schlingmann Karl-Peter , Konrad Martin

Background: Idiopathic infantile hypercalcemia (IIH) is a rare disorder caused by CYP24A1 loss-of-function mutation, resulting in impaired degradation of 1,25-dihydroxyvitamin D3. Typical signs include muscle hypotonia, dehydration, failure to thrive, psychomotor retardation, constipation, nephrocalcinosis. IIH should be distinguished from other causes of hypercalcemia in infancy. Treatment includes low calcium diet, glucocorticoids, furosemide, calcitonin. Pamidron...